Browse studies

Find your next paid study

36 recruiting studies matching your filters

Pilot Feasibility Study of a Mediterranean Diet Intervention for Hidradenitis Suppurativa

The goal of this clinical trial is to learn whether a 16-week Mediterranean-style dietary counseling program, called the Med-South Lifestyle Program (MSLP), is…

Hidradenitis Suppurativa

Estimated

~$10 – $6,250

University of North Carolina, Chapel HillNCT07800416

Phase 1

An Open-label Parallel Group Pilot Study to Demonstrate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa

This study is to investigate the efficacy of siplizumab in the treatment of Hidradenitis Suppurativa.

Hidradenitis Suppurativa

Estimated

~$10 – $6,250

University of Alabama at BirminghamNCT06326476

Phase 2

A Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase 2 Study of Brivekimig Followed by a Maintenance Period in Participants With Moderate to Severe Hidradenitis Suppurativa

This is a Phase 2b, global, multicenter, sequential, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study in participants with mode…

Hidradenitis Suppurativa

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-concept Trial to Assess the Efficacy and Safety of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa Receiving Standard of Care Treatment

This Phase 2 study will test whether the investigational medicine, SPY072, improves hidradenitis suppurativa (HS) in adults with moderate to severe disease rec…

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $8,750

Spyre Therapeutics, Inc.NCT07766005

Phase 2

A Phase 2, Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Povorcitinib in Adolescents With Moderate to Severe Hidradenitis Suppurativa

The purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of povorcitinib in adolescent participants with moderate to severe hidraden…

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $8,750

Incyte CorporationNCT07213973

Phase 2

A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study of NAV-240 in Adult Participants With Moderate-to-Severe Hidradenitis Suppurativa

The main objective of this study is to determine if NAV-240 works more effectively than a dummy treatment (placebo) for participants with moderate-to-severe HS…

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $8,750

Navigator Medicines, Inc.NCT07384975

Registry of Myriad™ Utilization in Soft Tissue Reconstruction Procedures

This is an observational study designed to evaluate the safety and clinical outcomes of Myriad™ in soft tissue reconstruction procedures. The study will enroll…

Abdominal Wound DehiscenceNecrotizing Soft Tissue InfectionLower Extremity Wound+4 more

Estimated

~$10 – $1,050

Aroa Biosurgery LimitedNCT05243966

Phase 2

An Open-Label Single Center Study Evaluating the Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa

This study investigates the efficacy of topical roflumilast foam in patients with HS.

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $7,500

Harrison DermatologyNCT07689188

Phase 2

An Open-label Single Center Study Evaluating the Safety and Efficacy of Roflumilast Foam 0.3% in Subjects With Hidradenitis Suppurativa

This study investigates the efficacy of topical roflumilast foam in patients with HS.

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $6,250

Beth Israel Deaconess Medical CenterNCT07263230

Observational

Outcomes With Pelashield™ PainGuard™ Compared to Restrata® in Standard Two-Stage Excision and Closure for Hidradenitis Suppurativa: A Prospective Cohort With Retrospective Comparator

Hidradenitis Suppurativa (HS) is a long-lasting skin condition that causes painful lumps and infections. In severe cases, patients need surgery to remove the a…

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $6,250

Rutgers, The State University of New JerseyNCT07316192

Observational

Radiotherapy for Treatment of Recalcitrant Hidradenitis Suppurativa (RADIANT-SUPPoRT)

The goal of this clinical trial is to learn if high-dose radiotherapy can provide sustained disease relief in moderate to severe, treatment resistant Hidradeni…

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $6,250

Thomas Jefferson UniversityNCT07414550

Phase 2

An Open Label Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam as a Mono or add-on Therapy in the Treatment of Hidradenitis Suppurativa With Correlative Analysis.

This is a phase 2a, open label study. As psoriasis and Hidradenitis Suppurativa (HS) share multiple inflammatory pathways, the investigators hypothesize that …

Hidradenitis Suppurativa

Estimated

~$10 – $6,250

Tulane UniversityNCT07077902